Get the Stockscreener App
1.80
6.25%
-0.12
Kiora Pharmaceuticals Inc stock is traded at $1.80, with a volume of 37,121.
It is down -6.25% in the last 24 hours and down -29.41% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$1.92
Open:
$1.94
24h Volume:
37,121
Relative Volume:
0.86
Market Cap:
$6.18M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1254
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-18.00%
1M Performance:
-29.41%
6M Performance:
-42.27%
1Y Performance:
-47.37%
1-Day Range:
$1.785
$1.99
1-Week Range:
$1.785
$2.23
52-Week Range:
$1.785
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
1.80 | 7.06M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Can Kiora Pharmaceuticals Inc. stock resist sector downturnsMarket Activity Report & Daily Profit Focused Screening - newser.com
Will Kiora Pharmaceuticals Inc. stock outperform growth indexes2025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
What analyst consensus implies for Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock beat Nasdaq index returns2025 Investor Takeaways & Safe Capital Growth Plans - newser.com
Why Kiora Pharmaceuticals Inc. (7EY) stock signals breakout potentialTrade Exit Summary & Expert Curated Trade Ideas - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.Quarterly Investment Review & Entry and Exit Point Strategies - newser.com
How moving averages guide Kiora Pharmaceuticals Inc. trading2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probabilityJuly 2025 Update & High Yield Stock Recommendations - newser.com
How to track smart money flows in Kiora Pharmaceuticals Inc.Gap Down & Weekly Market Pulse Alerts - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Using data filters to optimize entry into Kiora Pharmaceuticals Inc.Earnings Growth Summary & Weekly Market Pulse Updates - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitorsGDP Growth & Stock Portfolio Risk Control - newser.com
Published on: 2025-11-19 14:22:52 - newser.com
When is the best time to exit Kiora Pharmaceuticals Inc.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Why global investors buy Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
What candlestick patterns are forming on Kiora Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
Can Kiora Pharmaceuticals Inc. stock resist market sell offs2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-11-17 02:08:28 - newser.com
What analysts say about Kiora Pharmaceuticals Inc stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthQuarterly Profit Report & Weekly Market Pulse Updates - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investorsChart Signals & Safe Entry Momentum Tips - newser.com
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):